ArticleCureus2026
Leukocytoclastic Vasculitis Presenting With Peripheral Neuropathy and Foot Drop in an Adolescent: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Leukocytoclastic vasculitis (LCV) is a small-vessel vasculitis that typically presents with palpable purpura on the lower extremities and is often confined to the skin. Peripheral nerve involvement is uncommon. We describe the case of a 17-year-old female who developed progressive burning paresthesias in all four limbs, asymmetric sensory loss, autonomic symptoms, and left foot drop preceding the appearance of palpable purpura and necrotic lesions on both lower limbs. Nerve conduction studies demonstrated mixed demyelinating and axonal motor neuropathy in both lower limbs, more pronounced on the left, with additional motor axonal involvement of the right median nerve. Sympathetic skin responses were absent in all four limbs. An extensive evaluation for infectious, connective-tissue disease-related, antineutrophil cytoplasmic antibody-associated, and paraproteinemic causes was unrevealing. Skin punch biopsy demonstrated dermal perivascular inflammation, leukocytoclasis, erythrocyte extravasation, and fibrinoid necrosis of small-vessel walls; direct immunofluorescence was positive for complement component 3 (C3), immunoglobulin M (IgM), and IgA. These findings were consistent with LCV. The patient was treated with intravenous methylprednisolone followed by oral corticosteroids and hydroxychloroquine, along with two doses of rituximab. The patient demonstrated marked improvement in left ankle dorsiflexion, with Medical Research Council (MRC) muscle power improving from 2/5 to 4+/5, and was able to walk independently without assistance. No new skin lesions developed. This report highlights that neurologic manifestations may precede the characteristic cutaneous eruption of LCV and that early electrophysiologic assessment and tissue biopsy can facilitate prompt diagnosis and treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.